---
figid: PMC4598198__jir-8-181Fig2
figlink: /pmc/articles/PMC4598198/figure/f2-jir-8-181/
number: F2
caption: 'effect of lipoxins on cytoplasmic signaling cascades and transcription factors.Notes:
  Lipoxin binds to its G protein-coupled receptor ALX/Formyl peptidyl receptor triggering
  a wide array of cytoplasmic signaling cascades. Binding of lipoxin to its receptor
  ALX prevents binding of other pro-inflammatory ligands like SAA. Lipoxins could
  have alternative effects on PI3K and AKT pathway depending on the cell type. Lipoxins
  can control proliferation of immune cells and cancer cells by inhibiting growth
  promoting PI3K and AKT pathways. Lipoxins act to resolve inflammation by activating
  PI3K and AKT in macrophages to increase their life span. Lipoxin modulates levels
  of neutrophil for effective mounting and resolution of inflammation. They recruit
  neutrophils at the site of inflammation by increasing the cytosolic calcium levels
  and initiating pseudopodia movement, and at the same time control their proliferation
  by blocking MPO. Lipoxin controls synthesis and release of pro-inflammatory cytokines
  by increasing the mRNA level of suppressors of cytokine signaling and prevent transcription
  of inflammatory cytokines like IL-8 by inhibiting nuclear accumulation of NFκB and
  AP-1. Lipoxins are anti-angiogenic by blocking TNFα signaling. Lipoxins control
  the expression of inflammatory genes by decreasing levels of NFκB and AP-1 in the
  nucleus and increasing the levels of NAB1, Nrf2, and PPARγ. Green arrows indicate
  induction and red arrows indicate reduction in expression. Black lines indicate
  downstream biological events.Abbreviations: AP-1, activator protein-1; DAG, diacyl-glycerol;
  EGR1, early growth response 1 gene; ERK, extracellular signal-regulated kinase;
  IL-8, interleukin 8; IP3, inositol triphosphate; JAK, Janus kinase; MEK, mitogen-activated
  protein kinase kinase; MPO, myeloperoxidase; mTOR, mammalian target of rapamycin;
  NAB1, NGFIA binding protein 1; NFκB, Nuclear factor κB; Nrf2, nuclear factor like
  2; ONOO, peroxonitrite anion; PI3K, phosphatidylinositol-4,5-bisphosphate 3-kinase;
  PLD, phospholipase D; PPAR, peroxisome proliferator activated receptor; SAA, serum
  amyloid A; TNFα, tumor necrosis factor alpha; SOCS, suppressors of cytokine signaling;
  PIPP, polyisoprenyl phosphate.'
pmcid: PMC4598198
papertitle: 'Lipoxins: nature’s way to resolve inflammation.'
reftext: Jayashree A Chandrasekharan, et al. J Inflamm Res. 2015;8:181-192.
pmc_ranked_result_index: '63745'
pathway_score: 0.9613019
filename: jir-8-181Fig2.jpg
figtitle: 'effect of lipoxins on cytoplasmic signaling cascades and transcription
  factors.Notes: Lipoxin binds to its G protein-coupled receptor ALX/Formyl peptidyl
  receptor triggering a wide array of cytoplasmic signaling cascades'
year: '2015'
organisms:
- Homo sapiens
ndex: 3e865988-decf-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4598198__jir-8-181Fig2.html
  '@type': Dataset
  description: 'effect of lipoxins on cytoplasmic signaling cascades and transcription
    factors.Notes: Lipoxin binds to its G protein-coupled receptor ALX/Formyl peptidyl
    receptor triggering a wide array of cytoplasmic signaling cascades. Binding of
    lipoxin to its receptor ALX prevents binding of other pro-inflammatory ligands
    like SAA. Lipoxins could have alternative effects on PI3K and AKT pathway depending
    on the cell type. Lipoxins can control proliferation of immune cells and cancer
    cells by inhibiting growth promoting PI3K and AKT pathways. Lipoxins act to resolve
    inflammation by activating PI3K and AKT in macrophages to increase their life
    span. Lipoxin modulates levels of neutrophil for effective mounting and resolution
    of inflammation. They recruit neutrophils at the site of inflammation by increasing
    the cytosolic calcium levels and initiating pseudopodia movement, and at the same
    time control their proliferation by blocking MPO. Lipoxin controls synthesis and
    release of pro-inflammatory cytokines by increasing the mRNA level of suppressors
    of cytokine signaling and prevent transcription of inflammatory cytokines like
    IL-8 by inhibiting nuclear accumulation of NFκB and AP-1. Lipoxins are anti-angiogenic
    by blocking TNFα signaling. Lipoxins control the expression of inflammatory genes
    by decreasing levels of NFκB and AP-1 in the nucleus and increasing the levels
    of NAB1, Nrf2, and PPARγ. Green arrows indicate induction and red arrows indicate
    reduction in expression. Black lines indicate downstream biological events.Abbreviations:
    AP-1, activator protein-1; DAG, diacyl-glycerol; EGR1, early growth response 1
    gene; ERK, extracellular signal-regulated kinase; IL-8, interleukin 8; IP3, inositol
    triphosphate; JAK, Janus kinase; MEK, mitogen-activated protein kinase kinase;
    MPO, myeloperoxidase; mTOR, mammalian target of rapamycin; NAB1, NGFIA binding
    protein 1; NFκB, Nuclear factor κB; Nrf2, nuclear factor like 2; ONOO, peroxonitrite
    anion; PI3K, phosphatidylinositol-4,5-bisphosphate 3-kinase; PLD, phospholipase
    D; PPAR, peroxisome proliferator activated receptor; SAA, serum amyloid A; TNFα,
    tumor necrosis factor alpha; SOCS, suppressors of cytokine signaling; PIPP, polyisoprenyl
    phosphate.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FOSL1
  - MAPK3
  - JUNB
  - AKT3
  - EGR1
  - MPO
  - PIK3R3
  - INPP5J
  - PLCD3
  - PLCB1
  - PLCE1
  - PLCB2
  - PLCB3
  - AKT1
  - PIK3CG
  - FOSL2
  - JUN
  - PLD6
  - PLD3
  - PLD1
  - PLD2
  - MAPK1
  - PLCB4
  - PLCD1
  - AKT2
  - JUND
  - MAP2K2
  - NRAS
  - SAA1
  - SAA2
  - MTOR
  - NAB1
  - NFKB1
  - PIK3R6
  - PIK3R5
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - FOS
  - PIK3CD
  - FOSB
  - PLD4
  - PLD5
  - SAA4
  - CISH
  - STAT5A
  - STAT1
  - STAT2
  - ARAF
  - RAF1
  - PLCG1
  - MAP2K1
  - PLCD4
  - TNF
  - PLCZ1
  - BRAF
  - PLCG2
  - STAT3
  - STAT4
  - STAT6
  - PIK3R4
  - KRAS
  - PIK3CB
  - PIK3CA
  - HRAS
  - STAT5B
  - Lipoxins
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL1
  entrez: '8061'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUNB
  entrez: '3726'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: EGR1
  symbol: EGR1
  source: hgnc_symbol
  hgnc_symbol: EGR1
  entrez: '1958'
- word: MPO
  symbol: MPO
  source: hgnc_symbol
  hgnc_symbol: MPO
  entrez: '4353'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PIPP
  symbol: PIPP
  source: hgnc_alias_symbol
  hgnc_symbol: INPP5J
  entrez: '27124'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD3
  entrez: '113026'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB1
  entrez: '23236'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCE1
  entrez: '51196'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB2
  entrez: '5330'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB3
  entrez: '5331'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL2
  entrez: '2355'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: PLD
  symbol: PLD
  source: bioentities_symbol
  hgnc_symbol: PLD6
  entrez: '201164'
- word: PLD
  symbol: PLD
  source: bioentities_symbol
  hgnc_symbol: PLD3
  entrez: '23646'
- word: PLD
  symbol: PLD
  source: bioentities_symbol
  hgnc_symbol: PLD1
  entrez: '5337'
- word: PLD
  symbol: PLD
  source: bioentities_symbol
  hgnc_symbol: PLD2
  entrez: '5338'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB4
  entrez: '5332'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD1
  entrez: '5333'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUND
  entrez: '3727'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: SAA
  symbol: SAA
  source: bioentities_symbol
  hgnc_symbol: SAA1
  entrez: '6288'
- word: SAA
  symbol: SAA
  source: bioentities_symbol
  hgnc_symbol: SAA2
  entrez: '6289'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: NAB1
  symbol: NAB1
  source: hgnc_symbol
  hgnc_symbol: NAB1
  entrez: '4664'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSB
  entrez: '2354'
- word: PLD
  symbol: PLD
  source: bioentities_symbol
  hgnc_symbol: PLD4
  entrez: '122618'
- word: PLD
  symbol: PLD
  source: bioentities_symbol
  hgnc_symbol: PLD5
  entrez: '200150'
- word: SAA
  symbol: SAA
  source: bioentities_symbol
  hgnc_symbol: SAA4
  entrez: '6291'
- word: socs
  symbol: SOCS
  source: hgnc_alias_symbol
  hgnc_symbol: CISH
  entrez: '1154'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCG1
  entrez: '5335'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD4
  entrez: '84812'
- word: TNF
  symbol: TNF
  source: hgnc_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCZ1
  entrez: '89869'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCG2
  entrez: '5336'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT4
  entrez: '6775'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
chemicals:
- word: Lipoxins
  source: MESH
  identifier: D044045
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC4598198__F2
redirect_from: /figures/PMC4598198__F2
figtype: Figure
---
